In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 91 for your search:
Drug:  letrozole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000068583, NOVARTIS-CFEM345A-US10, NCT00014638

2.

Phase: Phase IV
Type: Diagnostic, Supportive care, Treatment
Status: Closed
Age: 40 to 65
Sponsor: Other
Protocol IDs: 2004/949, NCT00111241

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345EBR01, NCT00237133

4.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345DUS59, NCT00688909

5.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 45 and over
Sponsor: Other
Protocol IDs: KBCSG002, NCT00913016

6.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001JIL05, NCT01231659

7.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 11 SEIN 09, NCT01553903

8.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 11SEIN12, NCT01612871

9.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000456382, ACOSOG-Z1031, CALGB-ACOSOG-Z1031, SDC1, NCT00265759

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Postmenopausal
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GDE19, NCT00375752

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: MA17, U10CA025224, CAN-NCIC-MA17, CALGB-49805, E-JMA17, EORTC-10983, IBCSG-BIG97-01, NCCTG-JMA17, SWOG-JMA17, JRF-Vor-Int-10, NCCTG-CAN-MA17, SWOG-CAN-MA17, CDR0000065921, JMA17, NCT00003140

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-2026701025, CGS-20267, NCI-V98-1388

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor: Other
Protocol IDs: CDR0000067451, IBCSG-18-98, DAN-DBCG-IBCSG-1-98, FRE-FNCLCC-IBCSG-1-98, EU-99022, NOVARTIS-2026703019, BIG-1-98, IBCSG-1-98, BIG-I-98, NCT00004205

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGF30008, NCT00073528

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Biomed 777-CLP-29, NCT00044291

16.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000413877, NCCTG-N03CC, N03CC, NCT00107263

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 to 65
Sponsor: Other
Protocol IDs: TMH/153/2004, NCT00193778

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 50 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345D2407, NCT00171704

19.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: NCI-2009-00707, CDR0000472066, ECOG-PACCT-1, PACCT-1, U10CA021115, U10CA180820, NCT00310180

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345DFR04, NCT00329940

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345EGB07, NCT00330317

22.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345DDE09, NCT00332709

23.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CFEM345DDE10, NCT00332852

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age (postmenopausal)
Sponsor: NCI
Protocol IDs: NSABP B-42, U10CA012027, NCT00382070

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-10041, 2005-002625-31, BIG-3-04, EU-20676, NOVARTIS-EORTC-10041, ROCHE-EORTC-10041, SANOFI-AVENTIS-EORTC-10041, EUDRACT-2005-002625-31, NCT00433589
1     
New Search